Home › Funds › UBS Group AG › CDMO
UBS Group AG position in CDMO
AVID BIOSERVICES INC
Latest position (Q4 2024)794.86K sh
Reported value held$9.82M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 132.99K | $2.87M | New |
| Q4 2021 | 160.38K | $4.68M | Add |
| Q1 2022 | 207.94K | $4.24M | Add |
| Q2 2022 | 37.68K | $575.00K | Reduce |
| Q3 2022 | 24.56K | $470.00K | Reduce |
| Q4 2022 | 203.54K | $2.80M | Add |
| Q1 2023 | 75.46K | $1.42M | Reduce |
| Q2 2023 | 86.66K | $1.21M | Add |
| Q3 2023 | 54.05K | $510.27K | Reduce |
| Q4 2023 | 261.06K | $1.70M | Add |
| Q1 2024 | 326.62K | $2.19M | Add |
| Q2 2024 | 177.42K | $1.27M | Reduce |
| Q3 2024 | 185.44K | $2.11M | Add |
| Q4 2024 | 794.86K | $9.82M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.